Athyrium Capital Management, LP

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
New York, NY
CIK
0001728001
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 3 68,826 Omeros Corp, BIOR, PBYI 13F-HR 2/14/2024 000112329224000048
Q3 2023 6 113,555 Omeros Corp, Biora Inc., BIOR, PBYI 13F-HR 11/14/2023 000112329223000142
Q2 2023 7 154,146 Omeros Corp, Biora Inc., Paratek Pharmaceuticals Inc., RVLP 13F-HR 8/14/2023 000112329223000094
Q1 2023 8 279,118 AMYT, Biora Inc., Omeros Corp, RVLP RESTATEMENT 5/16/2023 000112329223000059
Q4 2022 11 237,928 AMYT, Biora Inc., Omeros Corp, RVLP 13F-HR 2/14/2023 000156761923002883
Q3 2022 11 267,004 Biora Inc., AMYT, Omeros Corp, CMAX 13F-HR 11/14/2022 000156761922020018
Q2 2022 11 237,754 Biora Inc., AMYT, Omeros Corp, BIOR 13F-HR 8/15/2022 000156761922016220
Q1 2022 10 281,299 Progenity Inc., AMYT, BIOR, Omeros Corp 13F-HR 5/16/2022 000156761922010942
Q4 2021 6 280,491 AMYT, Progenity Inc., BIOR, CMAX 13F-HR 2/14/2022 000156761922004383
Q3 2021 4 157,650 BIOR, AMYT, CMAX, SCTL 13F-HR 11/15/2021 000156761921020429
Q2 2021 4 239,861 BIOR, AMYT, CMAX, SCTL 13F-HR 8/16/2021 000156761921015856
Q1 2021 3 197,779 BIOR, AMYT, SCTL 13F-HR 5/17/2021 000156761921010489
Q4 2020 2 207,540 BIOR, AMYT 13F-HR 2/16/2021 000156761921004054
Q3 2019 1 5,073 KALA 13F-HR 11/14/2019 000156761919021532
Q2 2019 1 8,507 KALA 13F-HR 8/14/2019 000156761919016973
Q1 2019 2 97,853 AEGERION PHARMACEUTICALS INC, KALA 13F-HR 5/15/2019 000156761919011205
Q4 2018 3 103,805 AEGERION PHARMACEUTICALS INC, PTC THERAPEUTICS INC, KALA 13F-HR 2/12/2019 000156761919003291
Q3 2018 3 125,186 AEGERION PHARMACEUTICALS INC, PTC THERAPEUTICS INC, APEN 13F-HR 11/13/2018 000156761918005817
Q2 2018 3 92,483 AEGERION PHARMACEUTICALS INC, PTC THERAPEUTICS INC, APEN 13F-HR 8/14/2018 000156761918001098
Q1 2018 4 163,302 AEGERION PHARMACEUTICALS INC, VIVUS INC, PTC THERAPEUTICS INC, APEN 13F-HR 5/15/2018 000114036118023961
Q4 2017 5 169,055 AEGERION PHARMACEUTICALS INC, VIVUS INC, PTC THERAPEUTICS INC, SUCAMPO PHARMACEUTICALS INC 13F-HR 2/14/2018 000114036118007635
Additional filings from Athyrium Capital Management, LP that have since been restated